Skip to content

Henry Schein HSIC Deferred Tax Assets Capitalized Research And Development Costs

Deferred Tax Assets Capitalized Research And Development Costs at other companies

Corvex
 logo
Corvex MOVE
$5.16M-27.5%
Parker-Hannifin logo
Parker-HannifinPH
$172M+17.8%
PepsiCo logo
PepsiCoPEP
$134M-47.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$233.49M-27.8%
eBay logo
eBayEBAY
$435M-8.4%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$1.25B-26.5%

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept hsic:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts.

The official record: Henry Schein’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's deferred tax assets capitalized research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's deferred tax assets capitalized research and development costs?
Henry Schein (HSIC) reported deferred tax assets capitalized research and development costs of $10M in Q4 2025.
What is the long-term trend for Henry Schein's deferred tax assets capitalized research and development costs?
Over 2 years (2023 to 2025), Henry Schein's deferred tax assets capitalized research and development costs has grown at a -18.4% compound annual growth rate (CAGR), from $15M to $10M.
What does deferred tax assets capitalized research and development costs mean?
Future tax savings resulting from the tax treatment of capitalized R&D spending.
How do you interpret deferred tax assets capitalized research and development costs?
An increase indicates higher R&D investment that will provide future tax shields as the costs are amortized.
How does deferred tax assets capitalized research and development costs compare across companies?
Highly relevant for companies with significant R&D spending and specific tax jurisdictions that require R&D capitalization.